Back to search results

Drug Exposure and Minimum Inhibitory Concentration in the Treatment of MAC Lung Disease

Abroad (travel likely)Recruiting

Conditions

Mycobacterium Avium Complex · Mycobacterium Avium-Intracellulare Infection · Gram-Positive Bacterial Infections · Mycobacterium Infections

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Shanghai Pulmonary Hospital, Shanghai, China

    Contact: Study coordinator (Xubin Zheng, MPH, PhD) · xbzheng@tongji.edu.cn · 86 21 65115006
    Yidian Liu, MD, PhD (Sub-investigator)
    Li Wang, MD, PhD (Sub-investigator)
Study leads

  • Wei Sha, MD, Prof

    Principal Investigator

    Shanghai Pulmonary Hospital, Shanghai, China

  • Xubin Zheng, MPH, PhD

    Study Director

    Shanghai Pulmonary Hospital, Shanghai, China

  • Biao Xu, Prof

    Study Chair

    Fudan University

  • Jan-Willem Alffenaar, PhamD, Prof

    Study Chair

    University of Sydney

  • Judith Bruchfeld, Ass. Prof

    Study Chair

    Karolinska Institutet

  • Yi Hu, Ass. Prof

    Study Chair

    Fudan University

  • Lina Davies Forsman, MD, PhD

    Study Chair

    Karolinska Institutet

  • Yangyi Zhang, MPH

    Study Chair

    Shanghai Municipal Center for Disease Control and Prevention

View source on ClinicalTrials.gov(opens in a new tab)